Association between metabolic dysfunction associated steatotic liver disease and gallstones in the US population using propensity score matching by Yingying Zhang, Jingjing Zhang, Dan Yu, Fan Tu, Jun Liu, Bing Han, Binghua Li, Yihang Yuan, Chaobo Chen, Mingli Zhou

Subjects: “…Metabolic-associated steatotic liver disease…”
Get full text

Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification by Lili Fu, Zhongming Wu, Yanjun Chu, Wenbin Chen, Ling Gao, Shumin Mu, Jiajun Zhao

“…Astragalus mongholicus Bunge [Fabaceae] (AMB), a traditional Chinese medicine (TCM), has been widely used to treat liver diseases in the clinic. However, the efficacy and mechanism of AMB in the treatment of nonalcoholic fatty liver disease (NAFLD) remain unclear. …”
Get full text

Assessment of School Readiness in Chronic Cholestatic Liver Disease: A Pilot Study Examining Children with and without Liver Transplantation by Anna Gold, Alaine Rogers, Elizabeth Cruchley, Stephanie Rankin, Arpita Parmar, Binita M. Kamath, Yaron Avitzur, Vicky Lee Ng

“…Cognitive testing of preschool aged children with chronic liver disease may guide more timely interventions and focused efforts by health care providers. …”
Get full text

Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study by Rachael Morkem, Rebecca Theal, David Barber, Jennifer Flemming, John Queenan, Mohit Kehar

“…Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric chronic liver disease, and children with a body mass index (BMI) ≥95th percentile are recommended to be screened for NAFLD by liver enzymes. …”
Get full text

Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio by Jing Liu, Hongye Peng, Che Wang, Yutong Wang, Rongrui Wang, Jixiang Liu, Tianhui Zhou, Shukun Yao

“…As one of the most common chronic liver diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) had different prognoses between mild and moderate-severe levels. …”
Get full text

Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease by Fien A. von Meijenfeldt, Ton Lisman, Alessandra Pacheco, Yoh Zen, William Bernal

“…Background: Liver disease is often characterized by the activation of coagulation and inflammation. …”
Get full text

Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population by Guangya Chen, Yi Lv, Wei Ni, Qingxin Shi, Xingliang Xiang, Sen Li, Chengwu Song, Mingzhong Xiao, Shuna Jin

“…There is a limited diagnosis of nonalcoholic fatty liver disease (NAFLD). Thus, the noninvasive assessments are worth exploring. …”
Get full text

Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis by George Koulaouzidis, Dafni Charisopoulou, Michał Kukla, Wojciech Marlicz, Grażyna Rydzewska, Anastasios Koulaouzidis, Karolina Skonieczna-Żydecka

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease by Fei Chen, Jingjing An, Long Deng, Jing Wang, Ruiling He

Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text

Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study by Irena Ciećko-Michalska, Małgorzata Szczepanek, Beata Tobiasz-Adamczyk, Tomasz Mach

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Reduced Serum Glucagon Like Peptide-1 In Children with Osteoporosis of Chronic Liver Diseases: A Single Center Trial by Nashwa F. Mohamed Elmetwaly, Ola G. Behairy, Manal S. EL-Defrawy, Ola E. Seleim, Dina S. Abdelmotaleb

Subjects: Get full text

Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease by Omkolsoum Mohamed Alhaddad, Ayman Alsebaey, Mohamed Omar Amer, Hala Hany El-Said, Tary Abdel Hamid Salman

Get full text

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China by M. Ch. Semenistaya, Fan Jian-Gao, O. B. Velichenko, Ye. A. Kuznetsova, Ch. S. Pavlov

“…To present comparative assessment of diagnostic and treatment approaches at non-alcoholic fatty liver disease (NAFLD) in the Russian Federation and People’s Republic of China. …”
Get full text

Acute Viral Hepatitis-B in a COVID-19 Patient with Respiratory Failure by Seval SÖNMEZ YILDIRIM, Filiz KÜRKLÜ BOZKIR

Subjects: Get full text

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) by Po-Han Huang, Mary Patricia Nowalk, Richard K. Zimmerman, Samantha M. Olson, H. Keipp Talbot, Yuwei Zhu, Manjusha Gaglani, Kempapura Murthy, Arnold S. Monto, Emily T. Martin, Fernanda P. Silveira, G.K. Balasubramani

Subjects: Get full text

Telemedicine in the tertiary liver unit: A feasibility study by Daniel J. Havaj, Svetlana Adamcová-Selčanová, Klaudia Mesíková, Janka Vnenčáková, Daniela Žilinčanová, Natália Kubánek, Karolína K. Šulejová, Zuzana Mesárošová, Juraj Šváč, Radovan Lapuník, Viktória Ďurajová, Ľubomír Skladaný

Subjects: Get full text

A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice by Peng Ma, Rongrong Huang, Yu Ou

Subjects: “…Non-alcoholic fatty liver disease (NAFLD)…”
Get full text

Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress by Ju Zhou, Wu Li, Xiaowei Chi, Dingchun Li, Chunxia Yang, Zhiwen Duan

Subjects: “…metabolic dysfunction-associated steatotic liver disease (masld)…”
Get full text

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway by Peng Yu, Xi Xu, Jing Zhang, Xuan Xia, Fen Xu, Jianping Weng, Xiaoyang Lai, Yunfeng Shen

“…A glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (LR) had been experimentally and clinically shown to ameliorate nonalcoholic fatty liver disease (NAFLD). This study aimed to investigate the beneficial effect of LR on NAFLD in vivo and in vitro and its underlying molecular mechanism. …”
Get full text

Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus by Xiaoyi Qian, Wenwen Wu, Boyang Chen, Simin Zhang, Chunmei Xiao, Long Chen, Jun Chen, Jun Chen, Lingli Ke, Meian He, Xiulou Li, Xiulou Li, Xiulou Li

Subjects: “…nonalcoholic fatty liver disease…”
Get full text